home
company
science & technology
news & media
contact us
press releases
publications and presentations
 
Press Releases

CalciMedica Acquires Exclusive Rights to Novel Immune Signaling Targets for Treating Autoimmune Diseases from The CBR Institute
May 7, 2007

TorreyPines Therapeutics Transfers Intellectual Property and Compounds for Treating Autoimmune Diseases to CalciMedica
May 7, 2007


 
   

 

 

 

 

 

 

 

HOME | COMPANY | SCIENCE & TECHNOLOGY | NEWS & MEDIA | CONTACT US | SITE MAP | TERMS OF USE
© Copyright 2007 - CalciMedica